Transcript Document
Virus purification and analysis using OptiPrep™ - competitive media • Sucrose • Glycerol • Caesium chloride SOLUTION HANDLING • Density solutions prepared by diluting OptiPrep™ with culture medium or any balanced salt solution (Application Sheet V01) • Sterile solution • CsCl/sucrose solutions require lengthy preparation times and sterilization • CsCl is expensive CsCl PROBLEMS • Big losses in viral infectivity; low recoveries; high particle:infectivity ratios • Solutions have very high osmolality: viruses lose water; high virus density; high [CsCl] required for gradients • Highly toxic to cells: must be dialyzed prior to re-infection of cells • Solutions ionic and corrosive: samples must be dialyzed before electrophoresis or HPLC SUCROSE PROBLEMS (I) • Solutions are hyperosmotic: virus density in sucrose usually higher than in iodixanol • Solutions are viscous: slow sedimentation of virus particles • Highly toxic to cells: must be dialyzed prior to re-infection of cells OPTIPREP – NO PROBLEMS • Solutions are isoosmotic: virus density is low • Solutions have low viscosity: rapid sedimentation of virus particles • Is non-toxic to cells • Has little or no effect on virus infectivity • Cells can be re-infected and electrophoresis and HPLC performed without dialysis Virus banding density Virus CsCl Sucrose Iodixanol Epstein-Barr 1.26 Semliki Forest 1.26 1.18 1.18 Poliovirus 1.34 1.26 1.22 Measles 1.21 1.18 1.16 1.14 Effect of medium on PM2 infectivity Infectivity 1.1 1.3 1.5 1.7 CsCl g/ml Iodixanol 1012 Glycerol 1011 CsCl Sucrose 0 10 20 30 40 50 60 % iodixanol, sucrose, glycerol Kivela et al (1999)Virol. 262, 364-374 SUCROSE PROBLEMS (II): for enveloped viruses, particularly retroviruses • Sucrose gradients cause loss of virus surface glycoproteins; no loss with iodixanol gradients • Infectivity recoveries are 10-100x greater in iodixanol than in sucrose rAAV in discontinuous gradient (V04) Zolotukhin S. et al (1999) Gene Therapy, 6, 973-985 Virus fluid 15% iodixanol in 1 M NaCl 350,000g 1 h 25% iodixanol proteins 40% iodixanol 54% iodixanol adenovirus rAAV rAAV in continuous gradient (V04) Hermans, W.T.J.M.C. et al (1999) Human Gene Therapy, 10, 1885-1891 Virus fluid B OptiPrep Gradient Master Gradient Master profiles from 10% and 40% iodixanol at 80° and 20 rpm: effect of time Density (g/ml) 1.13 2 min 2.5 min 3.0 min 1.11 1.09 1.07 1 3 5 7 Fraction Number 9 3 Formats for separation of particles according to their density 1 2 3 rAAV in continuous gradient (V04) Virus fluid 348000g 3h membranes Hermans, W.T.J.M.C. et al (1999) Human Gene Therapy, 10, 1885-1891 OptiPrep rAAV Comparison of rAAV in CsCl and OptiPrep™ Pre-gradient Gradient % Recov’ry VP/ICU (NH4)2 SO4 CsCl 0.1-60 250-108 (NH4)2 SO4 OptiPrep 26-120 264-1333 Cellufine-SO4 OptiPrep 25-91 385-600 Data from Hermans, WTJMC et al (1999) Human Gene Therapy, 10, 1885-1891 Purification of HIV-1 (V06) Dettenhoffer, M & Yu, X-F (1999) J. Virol., 73 1460-1467 RT (cpmx10-5/ml) 6-18% iodixanol 250,000g for 1.5 h Soluble proteins Microvesicles Vif gene Use of self-generated iodixanol gradients in vertical rotors for virus purification and analysis Virus purification flow-chart – without virus pelleting 1 50,000g 2 1h 5 4 350,000g 1-3h 3 Purification of Herpes virus in selfgenerated 25% iodixanol gradient (V05) Log infectivity 6 1.3 5 1.25 4 1.2 3 1.15 2 1.1 1 1.05 0 1 3 5 7 9 11 Fraction Number 13 15 1 Density (g/ml) Infectivity Density Purification of retrovirus: self-generated gradient (V09) Moller-Larsen A & Christensen, T. (1998) J. Virol Meth., 73, 151-161 MS1533 MS1874 Density OD(PERT) x 10-2 25 1.25 1.2 20 1.15 15 1.1 10 5 1.05 0 1 1 3 5 7 9 11 13 15 17 19 Fraction number Density (g/ml) 30 OptiPrep™Application Sheets for: • • • • • • • • • Adenovirus Ebola virus Foamy virus Herpes simplex virus HIV-1 Human papillomavirus Lassa virus Murine leukemia virus Murine oncornavirus • • • • • • • • • Norwalk virus Polyoma virus rAAV Rabies virus Rous sarcoma virus Retroviruses Semliki Forest virus SARS Corona virus Vaccinia virus Publications database on viruses • OptiPrep (since 1994) over 600 • Nycodenz® (since 1984) approx 70 • Using either the Applications CD or the website: • www. axis-shield-density-gradient-media.com • Follow the instructions to access the relevant Index • Click on the virus of interest